PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8228399

Intrathecal baclofen for spinal spasticity: implications for nursing practice.

J Gianino
View original source ↗Export metadata ↓

Abstract

Treating severe spasticity with the continuous infusion of intrathecal baclofen through an implantable delivery system is a new and successful alternative to oral medications and ablative surgical procedures. Nurses have a vital role in patient care throughout all phases of therapy. Advances in this technology hold promise for our future in treating other neurologic disorders.

Explore related subjects

BaclofenHumansInfusion Pumps, ImplantableInjections, SpinalLong-Term CareMuscle SpasticityNervous System DiseasesPatient Care PlanningJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Gianino. 1993. Intrathecal baclofen for spinal spasticity: implications for nursing practice.. https://doi.org/10.1097/01376517-199308000-00011

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

[Efficacy of intrathecal baclofen in the treatment of spasticity in stroke].

OBJECTIVE: To determine whether intrathecal administration of baclofen reduced spastic hypertonia in a hemiplegic patient after hemorrhagic stroke. METHODS: A trial of intrathecal administration of baclofen was carried out with bolus injections of 50 and 75 microg baclofen and clinical and functional evaluation (Aschworth, articular amplitude) before and after injection in a patient with hemorrhagic stroke. After these trials, the placement of a pump was proposed to the patient. RESULTS: Aschworth score improved from 4 to 3 on triceps, quadriceps and adductus, with functional improvement of gait quality and perimeter and position in the wheelchair. Cephalgia, present before the treatment, increased after the implantation of the pump. The patient had some ejaculation trouble with the treatment, as well as some neurological pains after the pump implantation but experienced no effect on upper limbs. DISCUSSION: The intrathecal administration of baclofen has been used in some studies of hemiplegic patients, with reduced spasticity and improved the kinematic parameters of gait. The intrathecal baclofen administration could complement other treatment to control spasticity after stroke. CONCLUSION: Intrathecal baclofen administration could be an interesting complementary therapeutic among patients with important spasticity not controlled by the usual treatments.

Baclofen↗